Urs Hagemann

Urs Hagemann

Company: Bayer

Job title: Head of Targeted Radiopharmaceuticals


Roundtable Discussion – Understanding How to Choose the Correct Oncological Target to Adapt Your TRP to Changing Tumor Expressions 11:10 am

Navigating changing tumour expression Reflecting on how this expression affects target selection Analysing what makes a good target given changing tumour expressionRead more

day: Day 1 - Track A (AM)

Moulding Your TRP to Work Around the Challenges Associated With Novel Targets
9:50 am

Read more

day: Day 1 - Track A (AM)

Advancing Bayer’s (Pre)clinical TRT Pipeline 8:00 am

• Reviewing preclinical assets and modalities • Diving into combinations • Exploring the clinical assetsRead more

day: Conference Day 1

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.